Abstract: A method of selecting an active SIM for an emergency service and a multi-SIM device utilizing the same are disclosed. The method, adopted by the multi-SIM device, includes: receiving a request for an emergency call on a first SIM camping on an LTE network; determining whether a second SIM camps on a second communications network which supports an emergency service; and when the second communications network supports the emergency service, performing the emergency call from the second SIM.

Abstract: A multi-layered porous film is provided. The film includes a first porous layer having a first plurality of pores each with an aspect ratio of from 1:2 to 1:5; a second porous layer having a second plurality of pores each with an aspect ratio of from 1:2 to 1:5; and a thermal-resistance layer having a third plurality of pores, wherein the thermal-resistance layer is disposed between the first porous layer and the second porous layer, and has 50 wt % to 80 wt % of inorganic particles. A method for preparing the above multi-layered porous film is further provided.

Abstract: In an embodiment of the disclosure, a separator utilized in a lithium battery is provided. The separator includes a non-woven polyester support, a porous layer of polyvinylidene fluoride (PVDF) or its derivatives formed on the non-woven polyester support, a layer of UV-curing or thermal-curing polymers formed on top of the porous layer of polyvinylidene fluoride (PVDF) or its derivatives.

Abstract: The invention relates to a composition comprising a neuronal nicotinic receptor ligand and an ?4?2 positive allosteric modulator, a method of using the same, and a related article of manufacture.

Abstract: The present application relates to indole and indoline derivatives of formula (I), (II), (III), (IV), (V), or (VI) wherein a, R1, R2, R3, R4, R5, U, V, W, X, Y, and Z are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.

Abstract: The invention relates to a composition comprising a neuronal nicotinic receptor ligand and an ?4?2 positive allosteric modulator, a method of using the same, and a related article of manufacture.

Abstract: A method of selecting a SIM for a location service and a multi-SIM device utilizing the same are disclosed. The method, adopted by a multi-SIM device, includes: acquiring Secure User Plane Location (SUPL) information from a corresponding communications network which each SIM is in connection with; determining which communications network supports a location service based on the SUPL information; and requesting the location service on a SIM that is in connection with the supported communications network.

Abstract: A method of selecting an active SIM for an emergency service and a multi-SIM device utilizing the same are disclosed. The method, adopted by the multi-SIM device, includes: receiving a request for an emergency call on a first SIM camping on an LTE network; determining whether a second SIM camps on a second communications network which supports an emergency service; and when the second communications network supports the emergency service, performing the emergency call from the second SIM.

Abstract: A radio-frequency (RF) front-end supporting at least a first and second wireless communication bands includes a mixer arranged for mixing a received signal with a first local oscillation signal when the shared receiver front-end performs the reception operation according to the first wireless communication band, and for mixing the received signal with a second local oscillation signal when the shared receiver front-end performs the reception operation according to the second wireless communication band, wherein the first and second local oscillation signals are different in frequency.

Abstract: The present application relates to indole and indoline derivatives of formula (I), (II), (III), (IV), (V), or (VI) wherein a, R1, R2, R3, R4, R5, U, V, W, X, Y, and Z are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.

Abstract: The invention relates to compounds that are azaadamantane derivatives, particularly ether- or amine-substituted azaadamantane derivatives and salts and prodrugs thereof, compositions comprising such compounds, methods of using such compounds and compositions, processes for preparing such compounds, and intermediates obtained during such processes.

Abstract: This invention discloses a method of treatment of osteoarthritis pain by administration of a composition containing a nicotinic acetylcholine receptor ligand and a nicotinic acetylcholine receptor subtype ?4?2 allosteric modulator. The present application also relates to compositions comprising such compounds for use in treating pain and related disorders mediated by controlling neurotransmitter release in a subject.

Abstract: The invention relates to compounds that are azaadamantane derivatives, particularly ether- or amine-substituted azaadamantane derivatives and salts and prodrugs thereof, compositions comprising such compounds, methods of using such compounds and compositions, processes for preparing such compounds, and intermediates obtained during such processes.

Abstract: A communication device is provided with a processing unit. The processing unit determines whether at least one elementary file in a single subscriber identity card is required to be read out. If so, the processing unit activates one subscriber identity module instance in the subscriber identity card for the elementary file, and reads the elementary file from the subscriber identity card.

Abstract: The present invention is directed to methods of treating pain by administering a therapeutically effective amount of an ?7 nAChR ligand or a pharmaceutically acceptable salt thereof, to a mammal in need of treatment thereof and to pharmaceutical compositions comprising such a compound or salt.

Abstract: The invention relates to biaryl substituted azabicyclic alkane derivatives, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.

Abstract: Compounds of formula (I) wherein R3, R7, R9 and L are defined in the description are TRPV1 antagonists that exhibit low inhibitory activity against CYP3A4. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Abstract: A diplexer, for coupling a first radio frequency (RF) signal corresponding to a first carrier frequency and a second RF signal corresponding to a second carrier frequency is disclosed. The diplexer includes a first port arranged to couple the first RF signal; a second port arranged to couple the second RF signal; a third port capable of connecting an antenna; a first impedance unit coupled to the first port and the third port; and a second impedance unit coupled to the second port and the third port; wherein the first port, the second port and the third port are coupled to a direct current (DC) ground; wherein the first impedance unit is arranged to provide an first open-circuit impedance against the second RF signal, and the second impedance unit is arranged to provide a second open-circuit impedance against the first RF signal.

Abstract: Disclosed herein are compounds of formula (I) or pharmaceutically acceptable salts, solvates, or combinations thereof, wherein X1, X2, X3, X4, J, K, L, X5, X6, Rb, G2, and m are defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Abstract: The present application relates to indole and indoline derivatives of formula (I) wherein a, R1, R2, R3, h, i, j, m, n, L, Q, and X are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating disease conditions using such compounds and compositions.